Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025
   Core EBITDA Growth(%) 72.22-

What is the latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS is 72.22 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202672.22
Mar2025-

How is Core EBITDA Growth of FREDUN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 72.22
0
Mar2025 0 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹1,418.2 Cr -7.7% 12.2% 205.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹452,982.0 Cr 2% 6.7% 14.1% Stock Analytics
DIVIS LABORATORIES ₹179,361.0 Cr 3.5% 2.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹164,737.0 Cr 4.6% 9.9% 41.5% Stock Analytics
CIPLA ₹115,655.0 Cr -0.3% 3.7% -2.3% Stock Analytics
DR REDDYS LABORATORIES ₹112,573.0 Cr 1.1% 5.9% 6.6% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

-7.7%

12.2%

205.5%

SENSEX

-0.5%

3%

-8.5%


You may also like the below Video Courses